Great Lakes Advisors LLC trimmed its stake in Neogen Co. (NASDAQ:NEOG) by 3.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 121,517 shares of the company’s stock after selling 4,619 shares during the quarter. Great Lakes Advisors LLC owned 0.23% of Neogen worth $9,636,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. US Bancorp DE raised its position in shares of Neogen by 2.8% in the 4th quarter. US Bancorp DE now owns 56,050 shares of the company’s stock worth $4,444,000 after purchasing an additional 1,501 shares during the last quarter. UBS Asset Management Americas Inc. increased its position in shares of Neogen by 6.7% during the third quarter. UBS Asset Management Americas Inc. now owns 59,791 shares of the company’s stock valued at $4,679,000 after acquiring an additional 3,765 shares in the last quarter. Riverbridge Partners LLC increased its position in shares of Neogen by 6.3% during the fourth quarter. Riverbridge Partners LLC now owns 1,376,813 shares of the company’s stock valued at $109,181,000 after acquiring an additional 81,404 shares in the last quarter. Dupont Capital Management Corp raised its holdings in Neogen by 44.8% in the 3rd quarter. Dupont Capital Management Corp now owns 7,481 shares of the company’s stock worth $585,000 after acquiring an additional 2,315 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. lifted its position in Neogen by 3.9% in the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 30,335 shares of the company’s stock valued at $2,374,000 after acquiring an additional 1,136 shares in the last quarter. 92.79% of the stock is currently owned by hedge funds and other institutional investors.
NEOG stock opened at $83.57 on Tuesday. Neogen Co. has a 1-year low of $48.91 and a 1-year high of $89.32. The business has a fifty day moving average price of $84.40 and a 200-day moving average price of $77.41. The stock has a market capitalization of $4.45 billion, a P/E ratio of 73.31, a P/E/G ratio of 7.00 and a beta of 0.50.
In related news, Director William T. Boehm sold 3,000 shares of Neogen stock in a transaction on Tuesday, January 5th. The stock was sold at an average price of $80.72, for a total value of $242,160.00. Following the completion of the sale, the director now owns 13,479 shares of the company’s stock, valued at $1,088,024.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Jason Warren Lilly sold 11,021 shares of the company’s stock in a transaction on Wednesday, January 6th. The shares were sold at an average price of $82.91, for a total value of $913,751.11. Following the sale, the vice president now owns 18,032 shares of the company’s stock, valued at approximately $1,495,033.12. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 66,640 shares of company stock valued at $5,553,253. Company insiders own 0.90% of the company’s stock.
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells.
Further Reading: Benefits of owning preferred stock
Want to see what other hedge funds are holding NEOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Neogen Co. (NASDAQ:NEOG).
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.